The Radiopharmaceutical Theranostics Market Economic Outlook underscores a robust growth trajectory, driven by increasing prevalence of cancers, cardiovascular conditions, and neuroendocrine tumors. Government support, healthcare funding programs, and private investments are facilitating the expansion of nuclear medicine facilities globally. Declining costs of radioisotope production, combined...